Please provide your email address to receive an email when new articles are posted on . Tacrolimus may be promising for patients with psoriasis or atopic dermatitis who also have cardiovascular risk ...
Tacrolimus and cyclosporine A show similar efficacy in long-term survival and relapse reduction in AML post-transplant patients. No significant differences were found in leukemia-free survival, ...
Although tacrolimus is a recommended treatment for active lupus nephritis, it is associated with renal function decline over time. Tacrolimus use is associated with long-term kidney function decline ...
Please provide your email address to receive an email when new articles are posted on . Tacrolimus alone had a dose-response relationship with achieving complete renal response in SLE. Combination ...
In a cost-effectiveness analysis conducted in 2003, three primary therapy protocols for moderate to severe AD were compared: high-potency topical corticosteroids (HPTCs) limited to 2-week intervals, ...
Credit: Getty Images. The approval was based on an observational study using real-world data collected on all lung transplants in the US. The Food and Drug Administration (FDA) has approved Prograf ...
Medical Device Network on MSN
Thermo Fisher launches LDT to support tailored immunosuppressant dosing
Thermo Fisher’s LDT offers clinicians’ deeper insight into individual immunosuppressant dosing regimens for organ transplant patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results